(%)
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
- Ownership
-
DBV Technologies S.A. Insider Trading
* In original currency USD
Loading Data
Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price | Total Amount |
---|---|---|---|---|---|---|---|---|
Thursday, May 22nd, 2025 | Mohideen Pharis | officer: Chief Medical Officer | 110,113 | S-Sale | D | 397 | 1.84 USD | 731 USD |
Thursday, March 27th, 2025 | EPIC Bpifrance | other: Member of 10% owner group | 10,672,462 | 0 | 0.00 USD | 0 USD | ||
Thursday, March 27th, 2025 | EPIC Bpifrance | other: Member of 10% owner group | 226,133 | 0 | 0.00 USD | 0 USD | ||
Monday, April 7th, 2025 | EPIC Bpifrance | other: Member of 10% owner group | 0 | 6,556,781 | 0.00 USD | 0 USD | ||
Thursday, March 27th, 2025 | Bpifrance Investissement S.A.S. | other: Member of 10% owner group | 226,133 | 0 | 0.00 USD | 0 USD | ||
Thursday, March 27th, 2025 | Bpifrance SA | 10 percent owner | 10,672,462 | 0 | 0.00 USD | 0 USD | ||
Thursday, March 27th, 2025 | Bpifrance SA | 10 percent owner | 226,133 | 0 | 0.00 USD | 0 USD | ||
Monday, April 7th, 2025 | Bpifrance SA | 10 percent owner | 0 | 6,556,781 | 0.00 USD | 0 USD | ||
Thursday, March 27th, 2025 | BAKER BROS. ADVISORS LP | director, 10 percent owner: | 25,005,240 | A-Award | A | 25,005,240 | 0.00 USD | 0 USD |
Thursday, March 27th, 2025 | BAKER BROS. ADVISORS LP | director, 10 percent owner: | 25,005,240 | A-Award | A | 25,005,240 | 0.00 USD | 0 USD |
Thursday, March 27th, 2025 | BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2,299,656 | A-Award | A | 2,299,656 | 0.00 USD | 0 USD |
Thursday, March 27th, 2025 | BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2,299,656 | A-Award | A | 2,299,656 | 0.00 USD | 0 USD |
Thursday, January 30th, 2025 | Mohideen Pharis | officer: Chief Medical Officer | 110,510 | S-Sale | D | 600 | 0.85 USD | 510 USD |
Wednesday, December 4th, 2024 | Tasse Daniel | director, officer: CHIEF EXECUTIVE OFFICER | 813,200 | A-Award | A | 813,200 | 0.89 USD | 723,748 USD |
Friday, November 22nd, 2024 | Mohideen Pharis | officer: Chief Medical Officer | 111,675 | S-Sale | D | 342 | 0.53 USD | 181 USD |
Monday, November 25th, 2024 | Mohideen Pharis | officer: Chief Medical Officer | 111,110 | S-Sale | D | 565 | 0.57 USD | 322 USD |
Thursday, November 21st, 2024 | Mohideen Pharis | officer: Chief Medical Officer | 215,000 | A-Award | A | 215,000 | 0.75 USD | 161,250 USD |
Thursday, November 21st, 2024 | Mohideen Pharis | officer: Chief Medical Officer | 114,367 | A-Award | A | 35,000 | 0.00 USD | 0 USD |
Thursday, November 21st, 2024 | Mohideen Pharis | officer: Chief Medical Officer | 112,017 | S-Sale | D | 2,350 | 0.54 USD | 1,269 USD |
Thursday, November 21st, 2024 | Boucinha Virginie | officer: Chief Financial Officer | 113,000 | A-Award | A | 113,000 | 0.75 USD | 84,750 USD |
Thursday, November 21st, 2024 | Boucinha Virginie | officer: Chief Financial Officer | 38,000 | A-Award | A | 19,000 | 0.00 USD | 0 USD |
Monday, July 29th, 2024 | Mohideen Pharis | officer: Chief Medical Officer | 79,367 | S-Sale | D | 1,785 | 0.98 USD | 1,749 USD |
Wednesday, May 22nd, 2024 | Mohideen Pharis | officer: Chief Medical Officer | 81,812 | S-Sale | D | 382 | 1.38 USD | 527 USD |
Friday, May 24th, 2024 | Mohideen Pharis | officer: Chief Medical Officer | 81,152 | S-Sale | D | 660 | 1.36 USD | 898 USD |
Friday, March 8th, 2024 | Tasse Daniel | director, officer: CHIEF EXECUTIVE OFFICER | 17,094 | P-Purchase | A | 17,094 | 0.83 USD | 14,188 USD |
Tuesday, February 6th, 2024 | Ndu Adora | director | 1,825 | P-Purchase | A | 1,825 | 0.89 USD | 1,624 USD |
Wednesday, November 22nd, 2023 | Mohideen Pharis | officer: Chief Medical Officer | 82,194 | S-Sale | D | 2,245 | 1.74 USD | 3,906 USD |
Monday, November 20th, 2023 | Boucinha Virginie | officer: Chief Financial Officer | 113,000 | A-Award | A | 113,000 | 2.19 USD | 247,470 USD |
Monday, November 20th, 2023 | Boucinha Virginie | officer: Chief Financial Officer | 19,000 | A-Award | A | 19,000 | 0.00 USD | 0 USD |
Monday, November 20th, 2023 | Tasse Daniel | director, officer: Chief Executive Officer | 806,672 | A-Award | A | 806,672 | 2.19 USD | 1,766,612 USD |
Monday, November 20th, 2023 | Mohideen Pharis | officer: Chief Medical Officer | 215,000 | A-Award | A | 215,000 | 2.19 USD | 470,850 USD |
Monday, November 20th, 2023 | Mohideen Pharis | officer: Chief Medical Officer | 84,439 | A-Award | A | 35,000 | 0.00 USD | 0 USD |
Monday, November 6th, 2023 | Boucinha Virginie | officer | 0 | 0 | 0.00 USD | 0 USD | ||
Friday, August 25th, 2023 | MORRIS TIMOTHY E | director | 12,000 | P-Purchase | A | 12,000 | 1.52 USD | 18,240 USD |
Monday, November 21st, 2022 | Tasse Daniel | director, officer: Chief Executive Officer | 764,386 | A-Award | A | 764,386 | 3.07 USD | 2,346,665 USD |
Monday, November 21st, 2022 | Mohideen Pharis | officer: Chief Medical Officer | 115,000 | A-Award | A | 115,000 | 3.07 USD | 353,050 USD |
Friday, July 29th, 2022 | Mohideen Pharis | officer: Chief Medical Officer | 100,000 | A-Award | A | 100,000 | 4.83 USD | 483,000 USD |
Monday, November 21st, 2022 | Mohideen Pharis | officer: Chief Medical Officer | 51,700 | A-Award | A | 17,500 | 0.00 USD | 0 USD |
Thursday, November 24th, 2022 | Mohideen Pharis | officer: Chief Medical Officer | 49,908 | S-Sale | D | 1,792 | 2.88 USD | 5,161 USD |
Wednesday, May 24th, 2023 | Mohideen Pharis | officer: Chief Medical Officer | 49,439 | S-Sale | D | 469 | 3.54 USD | 1,660 USD |
Friday, July 29th, 2022 | Mohideen Pharis | officer: Chief Medical Officer | 34,200 | A-Award | A | 10,000 | 0.00 USD | 0 USD |
Monday, November 21st, 2022 | Robitaille Sebastien | officer: Chief Financial Officer | 65,000 | A-Award | A | 65,000 | 3.07 USD | 199,550 USD |
Monday, November 21st, 2022 | Robitaille Sebastien | officer: Chief Financial Officer | 36,500 | A-Award | A | 8,000 | 0.00 USD | 0 USD |
Tuesday, August 1st, 2023 | SOLAND DANIEL B | director | 20,000 | P-Purchase | A | 15,000 | 1.62 USD | 24,300 USD |
Monday, October 3rd, 2022 | Guyot-Caparros Daniele | director: | 0 | 0 | 0.00 USD | 0 USD | ||
Monday, June 13th, 2022 | BAKER BROS. ADVISORS LP | director, 10 percent owner: | 14,575,984 | A-Award | A | 10,622,568 | 0.00 USD | 0 USD |
Monday, June 13th, 2022 | BAKER BROS. ADVISORS LP | director, 10 percent owner: | 11,732,979 | A-Award | A | 11,732,979 | 0.00 USD | 0 USD |
Monday, June 13th, 2022 | BAKER BROS. ADVISORS LP | director, 10 percent owner: | 1,585,054 | A-Award | A | 1,252,432 | 0.00 USD | 0 USD |
Monday, June 13th, 2022 | BAKER BROS. ADVISORS LP | director, 10 percent owner: | 1,383,352 | A-Award | A | 1,383,352 | 0.00 USD | 0 USD |
Monday, June 13th, 2022 | Baker Brothers Life Sciences LP | director: | 1,383,352 | A-Award | A | 1,383,352 | 0.00 USD | 0 USD |
Monday, November 22nd, 2021 | Tasse Daniel | director, officer: Chief Executive Officer | 274,000 | A-Award | A | 274,000 | 6.62 USD | 1,813,880 USD |
Monday, November 22nd, 2021 | Mohideen Pharis | officer: Chief Medical Officer | 95,400 | A-Award | A | 95,400 | 6.62 USD | 631,548 USD |
Monday, November 22nd, 2021 | Mohideen Pharis | officer: Chief Medical Officer | 24,200 | A-Award | A | 8,700 | 0.00 USD | 0 USD |
Monday, November 22nd, 2021 | Robitaille Sebastien | officer: Chief Financial Officer | 51,000 | A-Award | A | 51,000 | 6.62 USD | 337,620 USD |
Monday, November 22nd, 2021 | Robitaille Sebastien | officer: Chief Financial Officer | 28,500 | A-Award | A | 5,000 | 0.00 USD | 0 USD |
Thursday, June 10th, 2021 | SOLAND DANIEL B | director | 6,837 | P-Purchase | A | 6,837 | 13.09 USD | 89,496 USD |
Thursday, June 10th, 2021 | Ndu Adora | director | 6,837 | P-Purchase | A | 6,837 | 13.09 USD | 89,496 USD |
Thursday, June 10th, 2021 | MORRIS TIMOTHY E | director | 6,837 | P-Purchase | A | 6,837 | 13.09 USD | 89,496 USD |
Thursday, June 10th, 2021 | Monges Viviane | director | 5,000 | P-Purchase | A | 5,000 | 13.09 USD | 65,450 USD |
Thursday, June 10th, 2021 | DE ROSEN MICHEL | director | 6,837 | P-Purchase | A | 6,837 | 13.09 USD | 89,496 USD |
Thursday, June 10th, 2021 | Rao Madduri Ravin | director | 6,837 | P-Purchase | A | 6,837 | 13.09 USD | 89,496 USD |
Wednesday, May 19th, 2021 | Rao Madduri Ravin | director: | 0 | 0 | 0.00 USD | 0 USD | ||
Wednesday, May 19th, 2021 | Ndu Adora | director: | 0 | 0 | 0.00 USD | 0 USD | ||
Tuesday, March 30th, 2021 | MORRIS TIMOTHY E | director: | 0 | 0 | 0.00 USD | 0 USD | ||
Friday, January 1st, 2021 | DE ROSEN MICHEL | director | 23,570 | D | 0 | 0.00 USD | 0 USD | |
Thursday, June 28th, 2018 | DE ROSEN MICHEL | director | 0 | D | 9,000 | 45.54 USD | 409,860 USD | |
Friday, January 1st, 2021 | GOLLER MICHAEL | director: | 0 | 0 | 0.00 USD | 0 USD | ||
Friday, January 1st, 2021 | BAKER BROS. ADVISORS LP | director, 10 percent owner: | 13,413,895 | I | 0 | 0.00 USD | 0 USD | |
Friday, January 1st, 2021 | BAKER BROS. ADVISORS LP | director, 10 percent owner: | 3,953,416 | I | 0 | 0.00 USD | 0 USD | |
Friday, January 1st, 2021 | BAKER BROS. ADVISORS LP | director, 10 percent owner: | 1,200,369 | I | 0 | 0.00 USD | 0 USD | |
Friday, January 1st, 2021 | BAKER BROS. ADVISORS LP | director, 10 percent owner: | 332,622 | I | 0 | 0.00 USD | 0 USD | |
Friday, January 1st, 2021 | BAKER BROS. ADVISORS LP | director, 10 percent owner: | 0 | I | 7,000 | 0.00 USD | 0 USD | |
Friday, January 1st, 2021 | Tasse Daniel | director, officer: Chief Executive Officer | 0 | D | 350,000 | 36.71 USD | 12,848,500 USD | |
Friday, January 1st, 2021 | Tasse Daniel | director, officer: Chief Executive Officer | 0 | D | 150,000 | 20.78 USD | 3,117,000 USD | |
Friday, January 1st, 2021 | Tasse Daniel | director, officer: Chief Executive Officer | 0 | D | 274,000 | 5.09 USD | 1,394,660 USD | |
Friday, January 1st, 2021 | SOLAND DANIEL B | director | 5,000 | D | 0 | 0.00 USD | 0 USD | |
Thursday, November 19th, 2015 | SOLAND DANIEL B | director | 0 | D | 7,500 | 80.79 USD | 605,925 USD | |
Wednesday, May 16th, 2018 | SOLAND DANIEL B | director | 0 | D | 7,000 | 45.54 USD | 318,780 USD | |
Tuesday, March 24th, 2015 | SOLAND DANIEL B | director | 0 | D | 10,000 | 52.59 USD | 525,900 USD | |
Friday, December 9th, 2016 | SOLAND DANIEL B | director | 0 | D | 7,000 | 85.30 USD | 597,100 USD | |
Friday, January 1st, 2021 | Robitaille Sebastien | officer: Chief Financial Officer | 23,500 | D | 0 | 0.00 USD | 0 USD | |
Friday, January 1st, 2021 | Robitaille Sebastien | officer: Chief Financial Officer | 0 | D | 51,000 | 5.09 USD | 259,590 USD | |
Thursday, June 15th, 2017 | O'Neill Julie | director | 0 | D | 9,000 | 72.22 USD | 649,980 USD | |
Wednesday, February 7th, 2018 | O'Neill Julie | director | 0 | D | 7,000 | 45.54 USD | 318,780 USD | |
Friday, January 1st, 2021 | Monges Viviane | director | 600 | D | 0 | 0.00 USD | 0 USD | |
Friday, January 1st, 2021 | Mohideen Pharis | officer: Chief Medical Officer | 15,500 | D | 0 | 0.00 USD | 0 USD | |
Friday, January 1st, 2021 | Mohideen Pharis | officer: Chief Medical Officer | 0 | D | 75,000 | 21.89 USD | 1,641,750 USD | |
Friday, January 1st, 2021 | Mohideen Pharis | officer: Chief Medical Officer | 0 | D | 95,400 | 5.09 USD | 485,586 USD | |
Sunday, June 12th, 2016 | Giraut Claire | director | 0 | D | 10,000 | 64.78 USD | 647,800 USD | |
Tuesday, June 26th, 2018 | Giraut Claire | director | 0 | D | 7,000 | 45.54 USD | 318,780 USD | |
Friday, January 1st, 2021 | Ferrere Mailys | director: | 0 | 0 | 0.00 USD | 0 USD | ||
Friday, January 1st, 2021 | Bjerke Torbjorn | director | 35,925 | D | 0 | 0.00 USD | 0 USD | |
Tuesday, June 26th, 2018 | Bjerke Torbjorn | director | 0 | D | 7,000 | 45.54 USD | 318,780 USD |